please report hbsag and hbeag as positive/negative, so new members might not be confused by those numbers.also try to find quantitative tests, using the qualitative for chronic carriers is useless
as to hbvdna it will be important to reach undetectable status by 6 months possibly although some patients may take even 12 months.the danger of developping resistance is high if hbvdna is still high after 6 months of entecavir
also why use entecavir if hbeag is postive?it has 5% hbsag clearance if not less while tenofovir has 16% hbsag clearance by 3 years and 0% resistance
My son's fibroscan result in Dec 2012 was 6.8kpa...started treatment using viread June 2013.....laboratory result in Dec 2013 indicates HBsAg quantitative declines significantly, HBV DNA declines significantly although not yet UND, fibroscan result 5.5kpa...
This site complies with the HONcode standard for trustworthy health information.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.